Clinical Response to Third-Line Angiotensin-II vs Epinephrine in Septic Shock: A Propensity-Matched Cohort Study

Background: The appropriate third-line vasopressor in septic shock patients receiving norepinephrine and vasopressin is unknown. Angiotensin-II (AT-II) offers a unique mechanism of action to traditionally used vasopressors in septic shock. Objective: The objective of this study was to compare the cl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of pharmacotherapy 2024-10, Vol.58 (10), p.1003-1012
Hauptverfasser:	Blankenship, Caitlyn R., Betthauser, Kevin D., Hencken, Laura N., Maamari, Julie A., Goetz, Jenna, Giacomino, Bria D., Gibson, Gabrielle A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin II - therapeutic use Cohort Studies Epinephrine - administration & dosage Epinephrine - therapeutic use Female Hospital Mortality Humans Male Middle Aged Norepinephrine - administration & dosage Norepinephrine - therapeutic use Propensity Score Retrospective Studies Shock, Septic - drug therapy Shock, Septic - mortality Treatment Outcome Vasoconstrictor Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!